Personalis Inc Equity-NMS: PSNL

$2.69 -0.09 (March 22, 2023)

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$2.78
Today's low :$2.69
52W low :$1.73
52W high :$10.09
1Y :-67.36%
5Y :-90.44%
EPS(TTM): :-2.48
Shares O/S :46.74 M
Market cap :125.72 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Personalis Inc today?

Personalis Inc (PSNL) share price as of March 22, 2023, is $2.69. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Personalis Inc?

Yes, Indian Investors can invest in the Personalis Inc (PSNL) Share by opening an international trading account with Angel One.

How can I purchase Personalis Inc shares in India?

Purchasing Personalis Inc (PSNL) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Personalis Inc (PSNL) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Personalis Inc?

Yes, you can purchase fractional shares of Personalis Inc (PSNL) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Personalis Inc?

The market capitalization of Personalis Inc on March 22, 2023, is $125.72 M.

In which sector Personalis Inc belongs?

Personalis Inc operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in Personalis Inc stocks?

In order to invest in Personalis Inc (PSNL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Personalis Inc

Personalis, Inc. is a cancer genomics company, which is engaged in providing precision cancer therapies and diagnostics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other next generation cancer immunotherapies. The NeXT platform is a next generation sequencing and analysis platform. The NeXT platform is designed to provide comprehensive analysis of both a tumor and its immune microenvironment from a single limited tissue or plasma sample. Its products are designed to detect recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Its research-focused products include exome sequencing, transcriptome sequencing, and targeted cancer panels. The Company’s platform analyses elements of the immune cells that have infiltrated a tumor both from the adaptive immune system and the innate immune system.